Humana Inc. (NYSE:HUM) Receives $291.35 Average Price Target from Analysts

Humana Inc. (NYSE:HUM) has received a consensus rating of “Hold” from the twenty-eight research firms that are covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation, sixteen have given a hold recommendation, eight have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $291.3478.

Several research firms have weighed in on HUM. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $425.00 target price on shares of Humana in a research report on Wednesday, June 3rd. Seaport Research Partners downgraded Humana to a “neutral” rating in a research report on Wednesday, May 20th. Royal Bank Of Canada reaffirmed a “sector perform” rating on shares of Humana in a research report on Monday, June 1st. Mizuho lifted their target price on Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Finally, Jefferies Financial Group raised Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th.

Humana Stock Performance

NYSE HUM opened at $360.84 on Friday. The company has a market cap of $43.32 billion, a P/E ratio of 38.59, a P/E/G ratio of 2.05 and a beta of 0.76. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The stock has a 50-day moving average of $285.88 and a two-hundred day moving average of $241.60. Humana has a 1-year low of $163.11 and a 1-year high of $380.86.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.Humana’s revenue was up 23.5% compared to the same quarter last year. During the same period in the previous year, the company posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, analysts anticipate that Humana will post 9.04 EPS for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is presently 37.86%.

Hedge Funds Weigh In On Humana

Several hedge funds and other institutional investors have recently made changes to their positions in HUM. Revolve Wealth Partners LLC purchased a new position in shares of Humana in the 4th quarter valued at about $202,000. Woodline Partners LP boosted its stake in shares of Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after buying an additional 8,372 shares during the period. Sivia Capital Partners LLC boosted its stake in shares of Humana by 53.7% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after buying an additional 452 shares during the period. Cresset Asset Management LLC boosted its stake in shares of Humana by 10.3% in the 2nd quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after buying an additional 222 shares during the period. Finally, WINTON GROUP Ltd boosted its stake in shares of Humana by 58.5% in the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock valued at $582,000 after buying an additional 879 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.